Literature DB >> 63950

Antiviral effect on MS-2 coliphage obtained with a synthetic antigen.

H Langbeheim, R Arnon, M Sela.   

Abstract

The coat protein of bacteriophage MS-2 was cleaved with cyanogen bromide to yield three fragments, possessing the sequence 1-88 (P1), 89-108 (P2), and 109-129 (P3), respectively. The mixture of peptides P2 and P3, which could not be separated, was found capable of inhibiting the neutralization of the phage by antiserum to the whole MS-2. The peptides corresponding to P2 and P3 were therefore synthesized. The synthetic P3 had no capacity to interfere with neutralization of MS-2, not did its macromolecular conjugate with multichain poly(DL-alanine) elicit neutralizing antibodies. On the other hand, the synthetic P2 was very efficient in inhibiting the inactivation of the phage by the antiserum against phage. Furthermore, a synthetic antigen prepared by attachment of P2 to multichain poly(alanine) incuded antiserum in rabbits that was capable of neutralizing MS-2 activity almost as efficiently as the antiserum prepared against the intact coat protein. This inactivation is specific, because it can, in turn, be totally inhibited by P2 peptide.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 63950      PMCID: PMC431576          DOI: 10.1073/pnas.73.12.4636

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  19 in total

1.  Preparation and properties of an artificial antigen immunologically related to tobacco mosaic virus.

Authors:  F A ANDERER
Journal:  Biochim Biophys Acta       Date:  1963-04-02

2.  Degradation of tobacco mosaic virus with acetic acid.

Authors:  H FRAENKEL-CONRAT
Journal:  Virology       Date:  1957-08       Impact factor: 3.616

3.  Antibodies to papain. A selective fractionation according to inhibitory capacity.

Authors:  R Arnon; E Shapira
Journal:  Biochemistry       Date:  1967-12       Impact factor: 3.162

Review 4.  Genetic control of specific immune responses.

Authors:  H O McDevitt; B Benacerraf
Journal:  Adv Immunol       Date:  1969       Impact factor: 3.543

5.  An analysis of the inactivation of MS2 bacteriophage with antiserum.

Authors:  I Rappaport
Journal:  J Gen Virol       Date:  1970-01       Impact factor: 3.891

6.  A selective fractionation of anti-lysozyme antibodies of different determinant specificities.

Authors:  R Arnon
Journal:  Eur J Biochem       Date:  1968-09-24

Review 7.  Enzyme inhibition by antibodies.

Authors:  R Arnon
Journal:  Acta Endocrinol Suppl (Copenh)       Date:  1975

8.  Reassembly of bacteriophage MS2 protein from 9 M urea.

Authors:  P J Oriel; P H Cleveland
Journal:  Virology       Date:  1970-12       Impact factor: 3.616

9.  Bacteriophage MS-2 in the immune response.

Authors:  H Snippe; M J de Reuver; M Belder; J M Willers
Journal:  Int Arch Allergy Appl Immunol       Date:  1976

10.  Contribution of different cell types to the genetic control of immune responses as a function of the chemical nature of the polymeric side chains (poly-L-prolyl and poly-DL-alanyl) of synthetic immunogens.

Authors:  G M Shearer; E Mozes; M Sela
Journal:  J Exp Med       Date:  1972-05-01       Impact factor: 14.307

View more
  17 in total

Review 1.  Viral pathogenesis and molecular biology.

Authors:  A S Huang
Journal:  Bacteriol Rev       Date:  1977-12

2.  Viral vaccines: the use of currently available products and future developments.

Authors:  E Norrby
Journal:  Arch Virol       Date:  1983       Impact factor: 2.574

3.  Antibodies against synthetic peptides of the B subunit of cholera toxin: crossreaction and neutralization of the toxin.

Authors:  C O Jacob; M Sela; R Arnon
Journal:  Proc Natl Acad Sci U S A       Date:  1983-12       Impact factor: 11.205

4.  Both cholera toxin-induced adenylate cyclase activation and cholera toxin biological activity are inhibited by antibodies against related synthetic peptides.

Authors:  C O Jacob; M Sela; M Pines; S Hurwitz; R Arnon
Journal:  Proc Natl Acad Sci U S A       Date:  1984-12       Impact factor: 11.205

5.  Adjuvant effect of a peptidoglycan attached covalently to a synthetic antigen provoking anti-phage antibodies.

Authors:  H Langbeheim; R Arnon; M Sela
Journal:  Immunology       Date:  1978-10       Impact factor: 7.397

6.  Successful immunization with a totally synthetic diphtheria vaccine.

Authors:  F Audibert; M Jolivet; L Chedid; R Arnon; M Sela
Journal:  Proc Natl Acad Sci U S A       Date:  1982-08       Impact factor: 11.205

Review 7.  Need for cellular and humoral immune responses in bovines to ensure protection from foot-and-mouth disease virus (FMDV)--a point of view.

Authors:  Y Becker
Journal:  Virus Genes       Date:  1994-07       Impact factor: 2.332

8.  Anti-influenza response achieved by immunization with a synthetic conjugate.

Authors:  G M Müller; M Shapira; R Arnon
Journal:  Proc Natl Acad Sci U S A       Date:  1982-01       Impact factor: 11.205

9.  Hepatitis B virus vaccine: identification of HBsAg/a and HBsAg/d but not HBsAg/y subtype antigenic determinants on a synthetic immunogenic peptide.

Authors:  A M Prince; H Ikram; T P Hopp
Journal:  Proc Natl Acad Sci U S A       Date:  1982-01       Impact factor: 11.205

10.  Antiviral response elicited by a completely synthetic antigen with built-in adjuvanticity.

Authors:  R Arnon; M Sela; M Parant; L Chedid
Journal:  Proc Natl Acad Sci U S A       Date:  1980-11       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.